U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Search AHRQ

For an exact phrase match, enclose search terms in double quotes.

Go to Advanced Search
Go to Basic Search

Results

Total Results: 589 records

Showing results for "chlamydia".

  1. Examples of Health Plan Quality Measures for Consumers | Agency for Healthcare Research and Quality

    pcmh.ahrq.gov/talkingquality/measures/setting/health-plan/examples.html
    December 01, 2022 - The percentage of health plan members receiving screenings for cancers, lead, glaucoma, Chlamydia, and

  2. Examples of Health Plan Quality Measures for Consumers | Agency for Healthcare Research and Quality

    pbrn.ahrq.gov/talkingquality/measures/setting/health-plan/examples.html
    December 01, 2022 - The percentage of health plan members receiving screenings for cancers, lead, glaucoma, Chlamydia, and

  3. Announcements | United States Preventive Services Taskforce

    www.uspreventiveservicestaskforce.org/uspstf/news/announcements?page=25
    May 27, 2014 - Recommendation Statements and Draft Evidence Reviews on Behavioral Counseling to Prevent STIs and Screening for Chlamydia

  4. Final Progress Report: Automated Lab Test Followup To Reduce Medical Errors (pdf file)

    www.ahrq.gov/sites/default/files/2025-03/greenes-report.pdf
    January 01, 2025 - We chose three types of tests for study: Chlamydia cultures, blood lead levels, and urine pregnancy … percent) with appropriate follow up documented Lead levels 18 12 (67%) Urine pregnancy tests 4 1 (25%) Chlamydia … to inadequate follow-up, was identified: a 19 year-old woman with a positive cervical culture for Chlamydia … These included 16 (41%) of the 39 Chlamydia cases in which no treatment for the infection was prescribed … positive for Corynebacterium 1 Positive Clostridium dificile toxin assay 4 Positive genital assay for Chlamydia

  5. Pelvic Inflammatory Disease | Effective Health Care (EHC) Program

    effectivehealthcare-admin.ahrq.gov/health-topics/pelvic-inflammatory-disease
    Gonorrhea and chlamydia , two sexually transmitted diseases, are the most common causes of PID.

  6. Appendix D. | Agency for Healthcare Research and Quality

    www.ahrq.gov/policymakers/chipra/measure_retirement/measure_retirementapd.html
    July 01, 2018 - Measure Name Chlamydia Screening in Women 4.b. … percentage of women ages 16 to 20 that were identified as sexually active and had at least one test for Chlamydia … during the measurement year. 5 Numerator At least one chlamydia test during the measurement

  7. Background Report for the Request for Public Comment on Initial, Recommended Core Set of Children's Healthcare Quality Measures for Voluntary Use by Medicaid and CHIP Programs | Agency for Healthcare Research and Quality

    www.cahps.ahrq.gov/policymakers/chipra/overview/background/next-steps2.html
    December 01, 2009 - screening tools for potential delays in social and emotional development among young children, and Chlamydia … Chlamydia screening for women. … This measure assesses the extent to which at least one Chlamydia test is given during the measurement … Chlamydia screening is important for adolescents. … Chlamydia is a sexually transmitted infection that causes pelvic inflammatory disease, a condition that

  8. Background Report for the Request for Public Comment on Initial, Recommended Core Set of Children's Healthcare Quality Measures for Voluntary Use by Medicaid and CHIP Programs | Agency for Healthcare Research and Quality

    www.healthcare411.ahrq.gov/policymakers/chipra/overview/background/next-steps2.html
    December 01, 2009 - screening tools for potential delays in social and emotional development among young children, and Chlamydia … Chlamydia screening for women. … This measure assesses the extent to which at least one Chlamydia test is given during the measurement … Chlamydia screening is important for adolescents. … Chlamydia is a sexually transmitted infection that causes pelvic inflammatory disease, a condition that

  9. Background Report for the Request for Public Comment on Initial, Recommended Core Set of Children's Healthcare Quality Measures for Voluntary Use by Medicaid and CHIP Programs | Agency for Healthcare Research and Quality

    www.monahrq.ahrq.gov/policymakers/chipra/overview/background/next-steps2.html
    December 01, 2009 - screening tools for potential delays in social and emotional development among young children, and Chlamydia … Chlamydia screening for women. … This measure assesses the extent to which at least one Chlamydia test is given during the measurement … Chlamydia screening is important for adolescents. … Chlamydia is a sexually transmitted infection that causes pelvic inflammatory disease, a condition that

  10. Background Report for the Request for Public Comment on Initial, Recommended Core Set of Children's Healthcare Quality Measures for Voluntary Use by Medicaid and CHIP Programs | Agency for Healthcare Research and Quality

    www.innovations.ahrq.gov/policymakers/chipra/overview/background/next-steps2.html
    December 01, 2009 - screening tools for potential delays in social and emotional development among young children, and Chlamydia … Chlamydia screening for women. … This measure assesses the extent to which at least one Chlamydia test is given during the measurement … Chlamydia screening is important for adolescents. … Chlamydia is a sexually transmitted infection that causes pelvic inflammatory disease, a condition that

  11. Background Report for the Request for Public Comment on Initial, Recommended Core Set of Children's Healthcare Quality Measures for Voluntary Use by Medicaid and CHIP Programs | Agency for Healthcare Research and Quality

    www.qualitymeasures.ahrq.gov/policymakers/chipra/overview/background/next-steps2.html
    December 01, 2009 - screening tools for potential delays in social and emotional development among young children, and Chlamydia … Chlamydia screening for women. … This measure assesses the extent to which at least one Chlamydia test is given during the measurement … Chlamydia screening is important for adolescents. … Chlamydia is a sexually transmitted infection that causes pelvic inflammatory disease, a condition that

  12. Background Report for the Request for Public Comment on Initial, Recommended Core Set of Children's Healthcare Quality Measures for Voluntary Use by Medicaid and CHIP Programs | Agency for Healthcare Research and Quality

    www.talkingquality.ahrq.gov/policymakers/chipra/overview/background/next-steps2.html
    December 01, 2009 - screening tools for potential delays in social and emotional development among young children, and Chlamydia … Chlamydia screening for women. … This measure assesses the extent to which at least one Chlamydia test is given during the measurement … Chlamydia screening is important for adolescents. … Chlamydia is a sexually transmitted infection that causes pelvic inflammatory disease, a condition that

  13. Background Report for the Request for Public Comment on Initial, Recommended Core Set of Children's Healthcare Quality Measures for Voluntary Use by Medicaid and CHIP Programs | Agency for Healthcare Research and Quality

    ce.effectivehealthcare.ahrq.gov/policymakers/chipra/overview/background/next-steps2.html
    December 01, 2009 - screening tools for potential delays in social and emotional development among young children, and Chlamydia … Chlamydia screening for women. … This measure assesses the extent to which at least one Chlamydia test is given during the measurement … Chlamydia screening is important for adolescents. … Chlamydia is a sexually transmitted infection that causes pelvic inflammatory disease, a condition that

  14. Supplemental Document 2 (pdf file)

    www.cahps.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/measure_retirement/supplemental-materials/supplementaldoc2.pdf
    September 01, 2014 - Chlamydia Screening (females ages 16– 20 years) Sexually active females ages 16–20 years (MAX … Chlamydia Screening (females ages 16– 20 years) Confidential See footnote m 35 (70%) … Health care quality improvement strategies of various kinds can improve rates of screening for chlamydia … Efficacy of interventions to increase the uptake of chlamydia screening in primary care: a systematic … Screening for asymptomatic Chlamydia infections among sexually active adolescent girls during pediatric

  15. Supplemental Document 2 (pdf file)

    www.monahrq.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/measure_retirement/supplemental-materials/supplementaldoc2.pdf
    September 01, 2014 - Chlamydia Screening (females ages 16– 20 years) Sexually active females ages 16–20 years (MAX … Chlamydia Screening (females ages 16– 20 years) Confidential See footnote m 35 (70%) … Health care quality improvement strategies of various kinds can improve rates of screening for chlamydia … Efficacy of interventions to increase the uptake of chlamydia screening in primary care: a systematic … Screening for asymptomatic Chlamydia infections among sexually active adolescent girls during pediatric

  16. Supplemental Document 2 (pdf file)

    www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/measure_retirement/supplemental-materials/supplementaldoc2.pdf
    September 01, 2014 - Chlamydia Screening (females ages 16– 20 years) Sexually active females ages 16–20 years (MAX … Chlamydia Screening (females ages 16– 20 years) Confidential See footnote m 35 (70%) … Health care quality improvement strategies of various kinds can improve rates of screening for chlamydia … Efficacy of interventions to increase the uptake of chlamydia screening in primary care: a systematic … Screening for asymptomatic Chlamydia infections among sexually active adolescent girls during pediatric

  17. Supplemental Document 2 (pdf file)

    www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/measure_retirement/supplemental-materials/supplementaldoc2.pdf
    September 01, 2014 - Chlamydia Screening (females ages 16– 20 years) Sexually active females ages 16–20 years (MAX … Chlamydia Screening (females ages 16– 20 years) Confidential See footnote m 35 (70%) … Health care quality improvement strategies of various kinds can improve rates of screening for chlamydia … Efficacy of interventions to increase the uptake of chlamydia screening in primary care: a systematic … Screening for asymptomatic Chlamydia infections among sexually active adolescent girls during pediatric

  18. Supplemental Document 2 (pdf file)

    www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/measure_retirement/supplemental-materials/supplementaldoc2.pdf
    September 01, 2014 - Chlamydia Screening (females ages 16– 20 years) Sexually active females ages 16–20 years (MAX … Chlamydia Screening (females ages 16– 20 years) Confidential See footnote m 35 (70%) … Health care quality improvement strategies of various kinds can improve rates of screening for chlamydia … Efficacy of interventions to increase the uptake of chlamydia screening in primary care: a systematic … Screening for asymptomatic Chlamydia infections among sexually active adolescent girls during pediatric

  19. Supplemental Document 2 (pdf file)

    www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/measure_retirement/supplemental-materials/supplementaldoc2.pdf
    September 01, 2014 - Chlamydia Screening (females ages 16– 20 years) Sexually active females ages 16–20 years (MAX … Chlamydia Screening (females ages 16– 20 years) Confidential See footnote m 35 (70%) … Health care quality improvement strategies of various kinds can improve rates of screening for chlamydia … Efficacy of interventions to increase the uptake of chlamydia screening in primary care: a systematic … Screening for asymptomatic Chlamydia infections among sexually active adolescent girls during pediatric

  20. Supplemental Document 2 (pdf file)

    ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/measure_retirement/supplemental-materials/supplementaldoc2.pdf
    September 01, 2014 - Chlamydia Screening (females ages 16– 20 years) Sexually active females ages 16–20 years (MAX … Chlamydia Screening (females ages 16– 20 years) Confidential See footnote m 35 (70%) … Health care quality improvement strategies of various kinds can improve rates of screening for chlamydia … Efficacy of interventions to increase the uptake of chlamydia screening in primary care: a systematic … Screening for asymptomatic Chlamydia infections among sexually active adolescent girls during pediatric
SHARE:
Facebook Twitter Print Facebook Share

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

Click to show only results for the selected site.

www.uspreventiveservicestaskforce.org (178)

www.ahrq.gov (62)

ce.effectivehealthcare.ahrq.gov (47)

digital.ahrq.gov (38)

www.qualitymeasures.ahrq.gov (37)

www.talkingquality.ahrq.gov (34)

www.innovations.ahrq.gov (32)

www.monahrq.ahrq.gov (32)

www.cahps.ahrq.gov (31)

www.healthcare411.ahrq.gov (30)

effectivehealthcare.ahrq.gov (12)

psnet.ahrq.gov (11)

hcup-us.ahrq.gov (10)

effectivehealthcare-admin.ahrq.gov (8)

pbrn.ahrq.gov (8)

qualityindicators.ahrq.gov (3)

cahps.ahrq.gov (2)

healthcare411.ahrq.gov (2)

monahrq.ahrq.gov (2)

pcmh.ahrq.gov (2)

talkingquality.ahrq.gov (2)

www.cpsi.ahrq.gov (2)

ahrqpubs.ahrq.gov (1)

patientregistry.ahrq.gov (1)

preventiveservices.ahrq.gov (1)

teamstepps.ahrq.gov (1)